Search results for "death"

showing 10 items of 1744 documents

RNA marker modifications reveal the necessity for rigorous preparation protocols to avoid artifacts in epitranscriptomic analysis

2021

Abstract The accurate definition of an epitranscriptome is endangered by artefacts resulting from RNA degradation after cell death, a ubiquitous yet little investigated process. By tracing RNA marker modifications through tissue preparation protocols, we identified a major blind spot from daily lab routine, that has massive impact on modification analysis in small RNAs. In particular, m6,6A and Am as co-varying rRNA marker modifications, appeared in small RNA fractions following rRNA degradation in vitro and in cellulo. Analysing mouse tissue at different time points post mortem, we tracked the progress of intracellular RNA degradation after cell death, and found it reflected in RNA modific…

Small RNAProgrammed cell deathRNABiologyRibosomal RNAIn vitroCell biologyCortex (botany)MiceRNA TransferRNA RibosomalTransfer RNAGeneticsAnimalsRNARNA Processing Post-TranscriptionalArtifactsIntracellularNucleic Acids Research
researchProduct

Differential Associations of Coping Strategies With Grief and Depression in Young Adults: The Role of Cause of Death and Relationship to the Deceased

2020

Introduction: The impact of loss by death in young adults has been underinvestigated, although higher rates of traumatic deaths are reported at this developmental stage. This study examined the relative differential consequences of bereavement-related factors for Persistent Complex Bereavement Disorder (PCBD) and depression. In addition, coping strategies predicting the study outcomes were examined as a function of bereavement-related factors.Methods: The study included 580 bereaved young adults with up to 5-year post loss. They were administered a battery of valided tools measuring PCBD symptoms, normal acute grief reactions as measured by the Core Bereavement Items scale, depressive sympt…

Social Psychologymedia_common.quotation_subject030227 psychiatry03 medical and health sciencesClinical Psychology0302 clinical medicineGriefYoung adultPsychology030217 neurology & neurosurgeryDepression (differential diagnoses)Clinical psychologyCause of deathmedia_commonJournal of Social and Clinical Psychology
researchProduct

Why Does Ingroup Identification Shield People from Death Anxiety?

2013

Research to date guided by terror management theory has demonstrated that mortality salience increases ingroup identification. However, the process that leads from death reminders to group investment has remained underinvestigated. We tested a model in which mortality salience increased the perceived continuity of the group while at the same time strengthening the perception of group entitativity. In turn, higher perceived group entitativity led to enhanced ingroup identification. Three-path mediation analysis showed that mortality salience transmitted its effects onto ingroup identification indirectly, progressing first through perceived collective continuity and then through ingroup enti…

Sociology and Political ScienceSocial Psychologymedia_common.quotation_subjectSelf-esteemTerror management theorymedicine.diseaseIngroups and outgroupsDeath anxietyEntitativityModerated mediationArts and Humanities (miscellaneous)PerceptionMortality saliencemedicinePsychologySocial psychologyGeneral Psychologymedia_commonSocial Psychology
researchProduct

Targeted therapy for hepatocellular carcinoma: novel agents on the horizon.

2012

Hepatocellular carcinoma (HCC) is the most common liver cancer, accounting for 90% of primary liver cancers. In the last decade it has become one of the most frequently occurring tumors worldwide and is also considered to be the most lethal of the cancer systems, accounting for approximately one third of all malignancies. Although the clinical diagnosis and management of early-stage HCC has improved significantly, HCC prognosis is still extremely poor. Furthermore, advanced HCC is a highly aggressive tumor with a poor or no response to common therapies. Therefore, new effective and well-tolerated therapy strategies are urgently needed. Targeted therapies have entered the field of anti-neopl…

SorafenibOncologymedicine.medical_specialtyPathologyCarcinoma Hepatocellularmedicine.medical_treatmentReviewsAntineoplastic AgentsDiseasesignal transduction inhibitorsModels BiologicalTargeted therapyInternal medicinemedicineCarcinomacancerAnimalsHumansMolecular Targeted TherapyHCCneoplasmsCause of deathbusiness.industryTherapies InvestigationalLiver NeoplasmsCancerDrugs Investigationalmedicine.diseasetargeted therapyVEGFdigestive system diseasesOncologyHepatocellular carcinomaRas/Raf/MEK/ERKHCC targeted therapy VEGF Ras/Raf/MEK/ERK PI3K/Akt/PTEN/mTOR signal transduction inhibitors cancPI3K/Akt/PTEN/mTORLiver cancerbusinessmedicine.drugSignal Transduction
researchProduct

What links BRAF to the heart function? new insights from the cardiotoxicity of BRAF inhibitors in cancer treatment

2015

The RAS-related signalling cascade has a fundamental role in cell. It activates differentiation and survival. It is particularly important one of its molecules, B-RAF. B-RAF has been a central point for research, especially in melanoma. Indeed, it lacked effective therapeutic weapons since the early years of its study. Molecules targeting B-RAF have been developed. Nowadays, two classes of molecules are approved by FDA. Multi-target molecules, such as Sorafenib and Regorafenib, and selective molecules, such as Vemurafenib and Dabrafenib. Many other molecules are still under investigation. Most of them are studied in phase 1 trials. Clinical studies correlate B-RAF inhibitors and QT prolonga…

SorafenibProto-Oncogene Proteins B-rafB-RAF inhibitorscardio-oncologySkin NeoplasmscardiotoxicityAntineoplastic AgentsReviewB-RAF inhibitorPharmacologyQT intervalSudden cardiac deathchemistry.chemical_compoundRegorafenibmedicineAnimalsHumansMolecular Targeted TherapydabrafenibVemurafenibMelanomaProtein Kinase InhibitorsCardiotoxicityClinical Trials as Topicbusiness.industryMelanomaB-RAFDabrafenibArrhythmias CardiacHeartmedicine.diseaseOncologychemistryCancer researchbusinessmedicine.drugSignal TransductionOncotarget
researchProduct

FEV1 and FVC predict all-cause mortality independent of cardiac function - Results from the population-based Gutenberg Health Study.

2017

Abstract Background Lung function has previously been related to increased mortality. Whether pulmonary impairment is associated with an increased mortality independent of cardiac dysfunction remains unclear. Methods In 15010 individuals from the general population (age range 35–74years, 51% men) in the Gutenberg Health Study we performed spirometry and transthoracic echocardiography. N-terminal pro-B-type natriuretic peptide (Nt-proBNP) and high-sensitive troponin I (hsTnI) were measured in all individuals. 1819 individuals with pulmonary diseases were excluded from further analysis. Results The median for forced expiratory volume in 1s (FEV1) was 94.2% and for forced vital capacity (FVC) …

SpirometryAdultMalemedicine.medical_specialtyVital capacityPopulationStatistics as TopicVital Capacity030204 cardiovascular system & hematology03 medical and health sciencesFEV1/FVC ratio0302 clinical medicineRisk FactorsInternal medicineCause of DeathForced Expiratory VolumeNatriuretic Peptide BrainmedicineHumansMortalityeducationLungAgedProportional Hazards Modelseducation.field_of_studyCOPDmedicine.diagnostic_testbusiness.industryHazard ratiorespiratory systemMiddle Agedmedicine.diseaseConfidence intervalPeptide Fragmentsrespiratory tract diseases030228 respiratory systemCardiovascular DiseasesEchocardiographyHeart failureCardiologyFemaleCardiology and Cardiovascular MedicinebusinessInternational journal of cardiology
researchProduct

Progressive Isolated Hypoglossal Nerve Palsy and Sudden Asphyzial Death

2008

Stab Wound Isolated Hypoglossal Nerve Palsy Sudden Death
researchProduct

Sarcophytolide: a new neuroprotective compound from the soft coral Sarcophyton glaucum

1998

Abstract Bioactivity-guided fractionation of an alcohol extract of the soft coral Sarcophyton glaucum collected from the intertidal areas and the fringing coral reefs near Hurghada, Red Sea, Egypt resulted in the isolation of a new lactone cembrane diterpene, sarcophytolide. The structure of this compound was deduced from its spectroscopic data and by comparison of the spectral data with those of known closely related cembrane-type compounds. In antimicrobial assays, the isolated compound exhibited a good activity towards Staphylococcus aureus, Pseudomonas aeruginosa , and Saccharomyces cerevisiae. Sarcophytolide was found to display a strong cytoprotective effect against glutamate-induced …

Staphylococcus aureusProgrammed cell deathSecondary metaboliteToxicologyNeuroprotectionCnidariaMicechemistry.chemical_compoundmedicineAnimalsRats WistarGlutamate receptorNeurotoxicityBiological activitymedicine.diseaseMolecular biologyRatsNeuroprotective AgentsProto-Oncogene Proteins c-bcl-2chemistryBiochemistryNMDA receptorCalciumDiterpenesDiterpenemedicine.drugToxicology
researchProduct

Selective killing of human monocytes and cytokine release provoked by sphingomyelinase (beta-toxin) of Staphylococcus aureus.

1996

The best-known activity of Staphylococcus aureus sphingomyelinase C, alias beta-toxin, is as a hemolysin that provokes hot-cold lysis of erythrocytes which contain substantial amounts of sphingomyelin in the plasma membrane. Sheep erythrocytes are most susceptible, and we found that one hemolytic unit, representing the toxin concentration that elicits 50% hemolysis of 2.5 X 10(8) erythrocytes per ml, corresponds to 0.05 enzyme units or to approximately 0.25 microg of sphingomyelinase per ml. The cytotoxic action of beta-toxin on nucleated cells has not been described in any detail before, and the present investigation was undertaken to fill this information gap. We now identify beta-toxin a…

Staphylococcus aureusTime FactorsLipopolysaccharideCD14ImmunologyBacterial ToxinsLipopolysaccharide ReceptorsExotoxinsMicrobiologyMonocytesMicrobiologychemistry.chemical_compoundHemolysin ProteinsPhospholipase A2Antigens CDmedicineHumansbiologyCell DeathDose-Response Relationship DrugCytotoxinsMonocyteHemolysinReceptors Interleukinmedicine.diseaseReceptors Interleukin-6HemolysisInfectious Diseasesmedicine.anatomical_structureSphingomyelin PhosphodiesteraseMechanism of actionchemistrybiology.proteinCytokinesParasitologymedicine.symptomSphingomyelinResearch ArticleInterleukin-1
researchProduct

Marginal hazard ratio estimates in joint frailty models for heart failure trials

2019

Abstract This work is motivated by clinical trials in chronic heart failure disease, where treatment has effects both on morbidity (assessed as recurrent non‐fatal hospitalisations) and on mortality (assessed as cardiovascular death, CV death). Recently, a joint frailty proportional hazards model has been proposed for these kind of efficacy outcomes to account for a potential association between the risk rates for hospital admissions and CV death. However, more often clinical trial results are presented by treatment effect estimates that have been derived from marginal proportional hazards models, that is, a Cox model for mortality and an Andersen–Gill model for recurrent hospitalisations. …

Statistics and ProbabilityBiometryleast false parameterDiseasejoint frailty modelRisk AssessmentStudy durationCardiovascular deathunexplained heterogeneitymedicineHumansTreatment effectComplex Regression ModelsProportional Hazards ModelsHeart FailureClinical Trials as TopicProportional hazards modelbusiness.industryheart failure trialsHazard ratioGeneral Medicinemedicine.diseaseClinical trialrecurrent eventsHeart failureAsymptomatic DiseasesStatistics Probability and UncertaintybusinessDemographyResearch PaperBiometrical Journal. Biometrische Zeitschrift
researchProduct